What color does blood typically appear as on a computed tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Appearance on CT Imaging

Acute blood appears bright white (hyperdense) on non-contrast CT scans, with attenuation values typically ranging from 50-90 Hounsfield Units, making it significantly brighter than surrounding brain tissue. 1

Acute Hemorrhage Characteristics

  • Acute bleeding demonstrates homogenous hyperdensity that is distinctly brighter than adjacent brain parenchyma 1
  • The hyperdense appearance results from high hemoglobin content in retracted clot or sedimented blood 2
  • Approximately 75% of acute hematomas exhibit regions of localized or diffuse hyperdensity on pre-contrast CT 2
  • The optimal cut-off for detecting acute thrombosis is 40-42 Hounsfield Units 1

Evolution of Blood Over Time

The appearance of blood on CT changes predictably as the hematoma ages:

  • Acute phase (hours to days): High attenuation/hyperdensity due to clot formation and retraction 1
  • Subacute phase (days to weeks): Mixed attenuation occurs as clot begins to lyse; may become isodense (same density) to brain tissue, making it difficult to visualize 1
  • Chronic phase (weeks to months): Low attenuation/hypodensity develops as tissue breakdown occurs and hemosiderin deposits form 1

Morphologic Variations

Blood can present with different patterns on CT depending on the stage and location:

  • Predominant hyperdensity throughout the lesion (48% of cases) 2
  • Linear shadows representing layering 2
  • Hyperdense filling defects surrounded by fluid 2
  • Dependent positioning of hyperdense fragments due to gravity 2
  • Fluid-fluid levels with dependent hyperdensity 2

Location-Specific Appearances

  • Intracerebral hemorrhage: Focal hyperdense mass within brain parenchyma 1
  • Subarachnoid hemorrhage: Hyperdensity in the subarachnoid spaces 1
  • Cerebral venous thrombosis: Acutely thrombosed veins and sinuses appear as homogenous hyperdensity, best visualized when CT slices are perpendicular to the vessel 1
  • Hyperdense vessel sign: High-density thrombus/embolus visible within an artery, indicating arterial occlusion 3

Critical Diagnostic Pitfalls

  • Non-contrast CT can be normal in early or small hemorrhages 1
  • Only 30% of cerebral venous thrombosis cases show abnormalities on initial non-contrast CT 1
  • Beam hardening artifact in the posterior fossa can limit detection of posterior circulation hemorrhages 1
  • If clinical suspicion remains high despite normal non-contrast CT, proceed immediately to CT angiography or MRI 1
  • Partial volume averaging with adjacent calcium, cerebrospinal fluid, or fatty material can alter the apparent density of small thrombi 1
  • Certain medications can cause unexpected intraluminal hyperdensities that may be mistaken for acute hemorrhage 4

Distinguishing Blood from Contrast Staining

After endovascular procedures, hyperdensity on CT may represent either hemorrhage or contrast staining:

  • Higher density measurements (Hounsfield Units >90) suggest hemorrhage with high specificity (94%) but low sensitivity (23%) 5
  • Hemorrhagic hyperdensities are associated with significantly higher mortality (50% versus 5.9%) compared to contrast staining alone 6
  • CT angiography can detect active bleeding at rates as low as 0.3 mL/min 1

Optimal Imaging Timing

  • CT should ideally be performed within 1 week of symptom onset to reliably demonstrate high density consistent with recent hemorrhage 1
  • MRI with gradient echo (GRE) sequences is particularly helpful for identifying small hemorrhages that CT may miss 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.